Gamnarai相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Efficacy of fourteen-day once-daily vonoprazan-based quadruple therapy for Helicobacter pylori in high clarithromycin-resistance regions (ONCE-VONO Trial)

在克拉霉素耐药性高的地区，以伏诺拉生为基础的四联疗法治疗幽门螺杆菌感染的14天疗效（ONCE-VONO试验）

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-27876-z

Sukkamolsantiporn, Saran; Bongkotvirawan, Phubordee; Chonprasertsuk, Soonthorn; Pornthisarn, Bubpha; Siramolpiwat, Sith; Bhanthumkomol, Patommatat; Issariyakulkarn, Navapan; Gamnarai, Pornpen; Wongcha-Um, Arti; Aumpan, Natsuda; Vilaichone, Virunpat; Sornchuer, Phornphan; Mahachai, Varocha; Miftahussurur, Muhammad; Yamaoka, Yoshio; Kitipawong, Peerapong; Vilaichone, Ratha-Korn

发表日期：2025

文献求助收藏

Efficacy of encapsulated fecal microbiota transplantation and FMT via rectal enema for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial (CAP-ENEMA FMT Trial)

经直肠灌肠进行封装粪便微生物移植和 FMT 治疗肠易激综合征的疗效：一项双盲、随机、安慰剂对照试验（CAP-ENEMA FMT 试验）

期刊:Frontiers in Medicine

doi:10.3389/fmed.2025.1648944

Aumpan, Natsuda; Chonprasertsuk, Soonthorn; Pornthisarn, Bubpha; Siramolpiwat, Sith; Bhanthumkomol, Patommatat; Issariyakulkarn, Navapan; Gamnarai, Pornpen; Bongkotvirawan, Phubordee; Wongcha-Um, Arti; Mahachai, Varocha; Vilaichone, Ratha-Korn

肠易激综合征

发表日期：2025

文献求助收藏

Fourteen-day vonoprazan-based bismuth quadruple therapy for H. pylori eradication in an area with high clarithromycin and levofloxacin resistance: a prospective randomized study (VQ-HP trial)

在克拉霉素和左氧氟沙星耐药性高的地区，采用 14 天伏诺拉生铋剂四联疗法根除幽门螺杆菌：一项前瞻性随机研究（VQ-HP 试验）

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-024-59621-3

Tungtrongchitr, Nuttapat; Bongkotvirawan, Phubordee; Ratana-Amornpin, Sarita; Siramolpiwat, Sith; Eiamsitrakoon, Thanee; Gamnarai, Pornpen; Wongcha-Um, Arti; Yamaoka, Yoshio; Pawa, Kammal Kumar; Vilaichone, Ratha-Korn

发表日期：2024

文献求助收藏

The use of real-world evidence to generate cost analysis of antibiotic susceptibility testing (AST) in patients with Helicobacter pylori treatment failure in Thailand: A large population-based study

利用真实世界证据对泰国幽门螺杆菌治疗失败患者的抗生素敏感性试验（AST）进行成本分析：一项基于大型人群的研究

影响因子:3.6

doi:10.1016/j.heliyon.2024.e39189

Aumpan, Natsuda; Gamnarai, Pornpen; Wongcha-Um, Arti; Miftahussurur, Muhammad; Yamaoka, Yoshio; Vilaichone, Ratha-Korn

发表日期：2024

文献求助收藏

FBPAII and rpoBC, the Two Novel Secreted Proteins Identified by the Proteomic Approach from a Comparative Study between Antibiotic-Sensitive and Antibiotic-Resistant Helicobacter pylori-Associated Gastritis Strains.

FBPAII 和 rpoBC 是通过对抗生素敏感型和抗生素耐药型幽门螺杆菌相关胃炎菌株的比较研究，利用蛋白质组学方法鉴定的两种新型分泌蛋白

期刊:Infection and Immunity

影响因子:2.8

doi:10.1128/IAI.00053-21

Kittisenachai Suthathip, Rojpibulstit Panadda, Vilaichone Ratha-Korn, Gamnarai Pornpen, Phaonakrop Narumon, Suealek Nuchanart

免疫/内分泌

发表日期：2021

文献求助收藏

Prevalence and Antibiotic Resistance Patterns of Helicobacter pylori Infection in Koh Kong, Cambodia

柬埔寨戈公省幽门螺杆菌感染的流行情况及抗生素耐药模式

期刊:Asian Pacific Journal of Cancer Prevention

doi:10.31557/APJCP.2020.21.5.1409

Aumpan, Natsuda; Vilaichone, Ratha-Korn; Gamnarai, Pornpen; Sanglutong, Likhasit; Ratanachu-Ek, Thawee; Mahachai, Varocha; Yamaoka, Yoshio

发表日期：2020

文献求助收藏

Extremely High Prevalence of Metronidazole-Resistant Helicobacter pylori Strains in Mountain People (Karen and Hmong) in Thailand

泰国山区居民（克伦族和苗族）中甲硝唑耐药幽门螺杆菌菌株的流行率极高

期刊:American Journal of Tropical Medicine and Hygiene

影响因子:1.6

doi:10.4269/ajtmh.15-0449

Vilaichone, Ratha-korn; Ratanachu-Ek, Thawee; Gamnarai, Pornpen; Chaithongrat, Supakarn; Uchida, Tomahisa; Yamaoka, Yoshio; Mahachai, Varocha

发表日期：2016

文献求助收藏

Hep88 mAb-initiated paraptosis-like PCD pathway in hepatocellular carcinoma cell line through the binding of mortalin (HSPA9) and alpha-enolase

Hep88 mAb 通过 mortalin (HSPA9) 和 α-烯醇化酶的结合，在肝细胞癌细胞系中启动类似副凋亡的程序性细胞死亡 (PCD) 通路。

期刊:Cancer Cell International

doi:10.1186/s12935-014-0069-9

Rojpibulstit, Panadda; Kittisenachai, Suthathip; Puthong, Songchan; Manochantr, Sirikul; Gamnarai, Pornpen; Jitrapakdee, Sarawut; Roytrakul, Sittiruk

细胞生物学

发表日期：2014

文献求助收藏